A. The Agriculture Improvement Act of 2018 changes certain federal authorities relating to the production and marketing of hemp, defined as cannabis (Cannabis sativa L.), and derivatives of cannabis with extremely low (less than 0.3 percent on a dry weight basis) concentrations of the psychoactive compound delta-9-tetrahydrocannabinol (THC). These changes include removing hemp from the Controlled Substances Act, which means that it will no longer be an illegal substance under federal law. However, Congress explicitly preserved the agency's current authority to regulate products containing cannabis or cannabis-derived compounds under the FD&C Act and section 351 of the Public Health Service Act. Please see the FDA’s statement on the signing of the Agriculture Improvement Act of 2018.
Of course, because legal marijuana is in such a confusing transitional period, even here there are potential exceptions. The U.S. Food and Drug Administration (FDA) approved Epidiolex, a treatment for a rare form of pediatric epilepsy that contains CBD. The DEA decided to classify this as a Schedule 5 drug, the scheduling that indicates the lowest potential for addiction and abuse.
Here’s a mind-blowing example: a study in 2014 found that people with THC in their systems were 80 percent less likely to die from traumatic head injuries than those without. THC is great for Insomnia “Indica” Recent research suggests it may also improve breathing while reducing sleep interruptions. Great news for those suffering from conditions such as sleep apnea! Fact, studies have confirmed that THC eases a variety of PTSD-related symptoms including agitation, depression, insomnia, flashbacks, and nightmares. Not only does the psychoactive protect brain cells, it also stimulates brain growth. Researchers have found that THC interacts with the same type of receptors in the hypothalamus that release the hormone ghrelin, which stimulates hunger. In fact, THC can even make food taste better. Interestingly, certain cannabis cultivars can also suppress appetite, which can be another advantage for a lot of people – weight loss. Enhances Senses! In 2008, researchers at MIT discovered that treating a concerning antibiotic-resistant pathogen with the psychoactive successfully killed the bacteria when other drugs could not even MRSA! As a potent antioxidant, one of the many health benefits of THC is protecting the body from stress-related damage. A known bronchodilator, studies conducted back in 1975 provided the first evidence of the cannabinoid’s ability to ease asthma attacks. While multiple cannabinoids show anti-cancer potential, THC is one of the main contenders! THC is a muscle relaxant on its own, the molecule’s ability to ease cramps and tension is a plus. THC also has anticonvulsant properties. Continuing 1 more time…
By the 1930s, marijuana was banned in 24 states. The newly minted Federal Bureau of Narcotics launched a campaign against the drug, and newspapers fueled hysteria with headlines like the 1933 Los Angeles Examiner's "Murder Weed Found Up and Down the Coast — Deadly Marihuana Dope Plant Ready for Harvest That Means Enslavement of California Children." By 1937, Congress passed the Marihuana Tax Act, which effectively banned marijuana except for a few medicinal purposes, according to "Smoke Signals: A Social History of Marijuana – Medical, Recreational and Legal" (Scribner, 2012).
CBD, or Cannabidiol, is a compound known as a cannabinoid. Cannabinoids are compounds that act on certain neurotransmitters throughout your body’s Endocannabinoid System (ECS). The ECS is responsible for regulating pain, inflammation, recovery time, sleep, and much more. When CBD is applied, consumed, or vaped, it encourages your ECS to produce more cannabinoids to reduce distress. The CBD in our Pain Rub may be able to alleviate pain and inflammation when it is applied to the desired area.
Information from adverse event reports regarding marijuana use is extremely limited; the FDA primarily receives adverse event reports for approved products. General information on the potential adverse effects of using marijuana and its constituents can come from clinical trials using marijuana that have been published, as well as from spontaneously reported adverse events sent to the FDA. Additional information about the safety and effectiveness of marijuana and its constituents is needed. Clinical trials of marijuana conducted under an IND application could collect this important information as a part of the drug development process.
The existence of substantial clinical investigations regarding CBD has been made public. For example, two such substantial clinical investigations include GW Pharmaceuticals’ investigations regarding Sativex and Epidiolex. (See Sativex Commences US Phase II/III Clinical Trial in Cancer Pain and GW Pharmaceuticals Receives Investigational New Drug (IND) from FDA for Phase 2/3 Clinical Trial of Epidiolex in the Treatment of Dravet Syndrome ).
In 2014, the Florida legislature passed SB 1030, which creates a registry ID card system for patients with cancer, seizure disorders, or severe and persistent muscle spasms that would allow them to possess and use only cannabis products rich in cannabidiol (CBD) and low in THC. In November 2016, voters approved Amendment 2, which will create a comprehensive medical cannabis program with significantly expanded qualifying conditions.

In 2015, The Hebrew University of Israel published a study that documented the potency of single-molecule CBD extract versus the potency of whole-plant CBD-rich extract. It found that extract taken from whole plant CBD-rich cannabis is therapeutically superior to single-molecule extract. The scientists behind this study noticed that science had been utilizing pure, single-molecule CBD, which resulted in a bell-shaped dose-response curve. This means that CBD’s efficacy plummets at very high and very low doses.
Cannabis (/ˈkænəbɪs/) is a genus of flowering plants in the family Cannabaceae. The number of species within the genus is disputed. Three species may be recognized: Cannabis sativa, Cannabis indica, and Cannabis ruderalis; C. ruderalis may be included within C. sativa; all three may be treated as subspecies of a single species, C. sativa;[1][2][3][4] or C. sativa may be accepted as a single undivided species.[5] The genus is widely accepted as being indigenous to and originating from Central Asia, with some researchers also including upper South Asia in its origin.[6][7]
This article will attempt to present information concerning cannabinoid mechanisms of analgesia, review randomized clinical trials (RCTs) of available and emerging cannabinoid agents, and address the many thorny issues that have arisen with clinical usage of herbal cannabis itself (“medical marijuana”). An effort will be made to place the issues in context and suggest rational approaches that may mitigate concerns and indicate how standardized pharmaceutical cannabinoids may offer a welcome addition to the pharmacotherapeutic armamentarium in chronic pain treatment.
Cibaderm® offers a full line of CBD hemp oil body care products. Their CBD Hemp Oil Body Wash contains a unique blend of CBD hemp oil and organic steam-distilled essential oils. The Cibaderm® Body Lotion is packed with 50 mg CBD Hemp Nourish™ to leave the skin silky soft. The Hand Cream contains 25 mg CBD combined with powerful antioxidants like vitamin E. Cibaderm® also offers innovative hemp CBD infused hair care products, including Hemp Shampoo and and CBD Hemp Soft™ Conditioner.
×